Vedolizumab
Vedolizumab-1015
Phase 2 small_molecule completed
Quick answer
Vedolizumab for Allogeneic Hematopoietic Stem Cell Transplantation is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Allogeneic Hematopoietic Stem Cell Transplantation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed